Venetoclax

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Venetoclax
CAS No.:1257044-40-8
Standard:In-house Standards
Price(USD):0.00
Company:Quanzhou Fortune Biopharma Co.,Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: QUANZHOU

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Venetoclax is a new type of anticancer drug, a Bcl-2 inhibitor developed by the American pharmaceutical company AbbVie, which is effective against cancer and produces less than current drugs. The side effects of this study were mainly done by researchers in the United States and Australia, and the results of the research were published in the international journal Nature Medicine.

    Indication: CLL(Chronic Lymphocytic Leukemia)

    All the products under the patent are only for R&D use.

    Patent from AbbVie, expiry date(The U.S):Jun.27, 2031.

Send your message to this supplier
  • From:
  • To:
    Quanzhou Fortune Biopharma Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service